Wednesday, November 27, 2024
Home Authors Posts by Editor / Curator

Editor / Curator

928 POSTS 0 COMMENTS
Aphex Biocleanse Systems
Superbug News - CoronaVirus Watch List

Aphex BioCleanse Further Expands Distribution Channels.

Editor / Curator -
CoronaVirus

Citius Pharma (CTXR) Updates Shareholders.

Editor / Curator -
@alanliverin
Bitcoin

Bitcoin $30,000. Time to Bargain Hunt? Read This First.

Editor / Curator -
Draganfly, Drone Investor
Drones

Integrated Launcher and Draganfly to Develop Drone-Based Non-Lethal Air Support Defense...

Editor / Curator -
Internet Stock Review
Stand Down

The Buffett Indicator. Tighten Your Safety Belts..

Editor / Curator -
Drones

Congress Meets to Discuss the American Security Drone Act.

Editor / Curator -
Cybersecurity

Drones Take Flight to Disinfect Sports, Entertainment Venues.

Editor / Curator -
ugro
Tiki Hut Fund

Seven of the World’s Top Performing Stocks, Every Morning.

Editor / Curator -
urban-gro
Marijuana Stock Review

Is urban-gro (UGRO) $7.50, the Most Undervalued Cannabis Play in the...

Editor / Curator -
Tiki Hut Fund

Seven of the World’s Top Performing Stocks, Every Morning.

Editor / Curator -
1...474849...93Page 48 of 93

Latest article

Nine Page Summary Report on GeoVax (GOVX)

2024 Watch List Editor / Curator -
This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

2024 Watch List Editor / Curator -
Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

All News Editor / Curator -
Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.